Vulvovaginal Candidiasis Treatment Market Share

Vulvovaginal Candidiasis Treatment Market Share

The competitive landscape of the vulvovaginal candidiasis (VVC) treatment market is characterized by the presence of several key players, including pharmaceutical companies, and biotechnology companies. These entities compete to develop and commercialize VVC treatments, aiming to capture market share and meet the evolving needs of patients.
 

Vulvovaginal Candidiasis Treatment Market Companies 

Prominent players operating in the vulvovaginal candidiasis treatment industry include:

• Accord Healthcare Ltd.
• Amneal Pharmaceuticals LLC
• Astellas Pharma Inc.
• Basilea Pharmaceutica Ltd.
• Bayer AG
• Bristol-Myers Squibb Company
• Grupo Ferrer Internacional S.A.
• Johnson & Johnson
• Mycovia Pharmaceuticals, Inc.
• Mylan N.V.
• Pfizer, Inc.
• Scynexis, Inc.
• Teva Pharmaceutical Industries Ltd.
• Zydus Cadila